Alzheimer’s Detection: Brain Signal Predicts Disease Early
- Scientists at Brown University have discovered a brain-based biomarker that may predict the progression of mild cognitive impairment (MCI) to Alzheimer's disease.
- The biomarker identifies a specific pattern in the electrical signals of brain activity that correlates with the likelihood of developing Alzheimer's disease within approximately two and a half...
- "We've detected a pattern in electrical signals of brain activity that predicts which patients are most likely to develop the disease within two and a half years," said...
Brown university Identifies Brain Biomarker for Alzheimer’s Prediction
Table of Contents
Scientists at Brown University have discovered a brain-based biomarker that may predict the progression of mild cognitive impairment (MCI) to Alzheimer’s disease. The research, utilizing a specialized analysis tool, focuses on measuring electrical activity in neurons to identify early signs of the disease directly within the brain.
How the Biomarker Works
The biomarker identifies a specific pattern in the electrical signals of brain activity that correlates with the likelihood of developing Alzheimer’s disease within approximately two and a half years. This noninvasive method offers a new approach to early detection.
“We’ve detected a pattern in electrical signals of brain activity that predicts which patients are most likely to develop the disease within two and a half years,” said stephanie Jones, a professor of neuroscience affiliated with Brown’s Carney Institute for Brain Science and co-leader of the research. “Being able to noninvasively observe a new early marker of Alzheimer’s disease progression in the brain for the first time is a very exciting step.”
Mild Cognitive Impairment and Alzheimer’s Disease
Mild cognitive impairment (MCI) is a condition characterized by cognitive decline greater than expected for an individual’s age and education level, but not severe enough to interfere with daily life. Not everyone with MCI develops Alzheimer’s disease, making early prediction crucial for intervention. The Alzheimer’s Association estimates that approximately 10-20% of people with MCI progress to Alzheimer’s each year.
The Carney Institute for Brain Science
The research was conducted at Brown University‘s Carney Institute for Brain Science, a leading center for neuroscience research. The institute focuses on understanding the complexities of the brain and developing new treatments for neurological disorders. the institute’s work spans a range of disciplines,including neurobiology,cognitive science,and clinical neurology.
Future Implications
This revelation could led to earlier diagnosis and intervention strategies for Alzheimer’s disease. Early detection allows for potential lifestyle changes,participation in clinical trials,and management of symptoms. Further research is needed to validate these findings in larger and more diverse populations. as of January 12, 2026, there have been no reported updates to this research indicating changes to the 2.5 year prediction timeframe or the biomarker’s efficacy. Brown University News continues to be the primary source for updates on this research.